Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.86x is 156% above its 5-year average of -1.54x, near the high end of its 5-year range (-26.88x–2.34x).
25.54% below its 12-month average of 1.15x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.74x.
INTEREST COVERAGE RATIO
0.86x
INTEREST COVERAGE RATIO AVG TTM
1.15x
INTEREST COVERAGE RATIO AVG 3Y
-0.29x
INTEREST COVERAGE RATIO AVG 5Y
-1.54x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-25.54%
CURRENT VS 3Y AVG
+401.55%
CURRENT VS 5Y AVG
+155.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+113.49%
vs the sector median at left
Xeris Biopharma Holdings, Inc.
Market Cap
$1.74B
Interest Coverage Ratio
0.86x
TTM Avg
1.15x
3Y Avg
-0.29x
5Y Avg
-1.54x
Market Cap
$1.74B
Interest Coverage Ratio
-596.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
0.93x
TTM Avg
0.93x
3Y Avg
0.93x
5Y Avg
0.93x
Market Cap
$1.73B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Interest Coverage Ratio
1.43x
TTM Avg
1.58x
3Y Avg
1.58x
5Y Avg
1.43x
Market Cap
$1.71B
Interest Coverage Ratio
-429.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.77B
Interest Coverage Ratio
-206.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | $1.74B | 0.86x | 1.15x | -0.29x | -1.54x |
| Absci Corporation (ABSI)vs › | $1.74B | -596.74x | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 0.93x | 0.93x | 0.93x | 0.93x |
| Novocure Ltd (NVCR)vs › | $1.74B | N/A | 1.68x | 1.68x | 1.68x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.43x | 1.58x | 1.58x | 1.43x |
| Personalis, Inc. (PSNL)vs › | $1.71B | -429.55x | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -206.92x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 2.86x | 2.86x | 2.86x | 6.42x |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | -28.85x | N/A | N/A | N/A |
Interest Coverage
0.9x
Debt/Equity
N/A
Current Ratio
1.45
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.74x |
| 2026-03-31 | 1.15x |
| 2025-12-31 | 2.34x |
| 2025-09-30 | 0.93x |
| 2025-06-30 | 0.61x |
| 2025-03-31 | -0.42x |
| 2024-12-31 | 0.22x |
| 2024-09-30 | -1.66x |
| 2024-06-30 | -1.03x |
| 2024-03-31 | -2.03x |
| 2023-12-31 | -1.40x |
| 2023-09-30 | -0.72x |
| 2023-06-30 | -2.45x |
| 2023-03-31 | -2.14x |
| 2022-12-31 | -3.47x |
| 2022-09-30 | -4.71x |
| 2022-06-30 | -5.49x |
| 2022-03-31 | -8.26x |
| 2021-12-31 | -26.88x |
| 2021-09-30 | -13.55x |
| 2021-06-30 | -14.37x |
| 2021-03-31 | -9.35x |
| 2020-12-31 | -4.21x |
| 2020-09-30 | -5.90x |
| 2020-06-30 | -9.90x |
| 2020-03-31 | -18.85x |
| 2019-12-31 | -21.42x |
| 2019-09-30 | -8.58x |
| 2019-06-30 | -32.07x |
| 2019-03-31 | -23.93x |
| 2018-12-31 | -19.25x |
| 2018-09-30 | -20.28x |
| 2018-06-30 | -21.99x |
| 2018-03-31 | -61.41x |
| 2017-12-31 | -9209.00x |
| 2017-06-30 | -5199.00x |
